Detalhe da pesquisa
1.
Dupilumab in patients with chronic spontaneous urticaria (LIBERTY-CSU CUPID): Two randomized, double-blind, placebo-controlled, phase 3 trials.
J Allergy Clin Immunol
; 2024 Feb 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38431226
2.
Safety, tolerability and efficacy of lixisenatide in combination with oral antidiabetic treatment in Japanese patients with type 2 diabetes: An open-label, multicenter study.
J Diabetes Investig
; 9(1): 127-136, 2018 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-28429860